Novonesis (Novozymes) B/ DK0060336014 /
21/05/2024 14:55:36 | Diferencia - | Volumen | Bid9:00:02 | Ask9:00:02 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
427.05DKK | - | 303 Volumen de negocios: 129,460.10 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 115.28 mil millonesDKK | 1.45% | 31.12 |
GlobeNewswire
22:46
Biogen Inc. (Nasdaq: BIIB) Investors Notice: Class action lawsuit filed on behalf of investors; the ...
GlobeNewswire
22:45
Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq ...
GlobeNewswire
22:43
Li Auto Inc. (LI) Investors: July 9, 2024 Filing Deadline in Securities Class Action - Contact Kessl...
GlobeNewswire
22:30
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
GlobeNewswire
22:30
X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinica...
GlobeNewswire
22:30
Clip Partners with Leading ATM Operator for Expanded Cash Deposit Pilot with Nationwide Convenience ...
GlobeNewswire
22:18
Investors Oddity Tech Ltd. (ODD) Investors: Company Investigated by the Portnoy Law Firm
GlobeNewswire
22:15
Palomar Holdings, Inc. Announces Participation in the William Blair 44th Annual Growth Stock Confere...
GlobeNewswire
22:15
AMSC Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Outlook
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página